Related Experiment Video

Updated: Jun 5, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Elimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules

Xiaoyu Wen1, Takayuki Abe, Hiroshi Kukihara

  • 1Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Plos One
|January 22, 2011
PubMed

Insights

New therapeutic molecules selectively target and eliminate hepatitis C virus (HCV) in infected liver cells. These engineered proteins activate antiviral responses, offering a potential strategy for HCV eradication.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) infection poses a significant global health challenge.
  • Current treatments may face limitations, necessitating novel therapeutic strategies.
  • Targeting viral replication within infected hepatocytes is crucial for HCV elimination.

Purpose of the Study:

  • To develop novel therapeutic molecules for selective elimination of HCV in infected hepatocytes.
  • To engineer molecules activated specifically by HCV-infected cells to minimize off-target effects.
  • To assess the antiviral efficacy of these novel molecules against HCV replication.

Main Methods:

  • Generation of two therapeutic molecules, cIRF7 and cVAP-C, by fusing functional protein domains with an HCV protease-cleavable linker.
  • Localization of the modified linker to the ER membrane for precise cleavage.
  • Expression of therapeutic molecules in HCV replicon cells and cells infected with HCVcc (JFH1 strain).

Main Results:

  • cIRF7, upon cleavage by HCV protease, translocates to the nucleus and activates interferon (IFN) promoters (IFNα6, IFNβ, ISRE).
  • Expression of cIRF7 suppressed viral RNA replication in both HCV replicon and HCVcc infected cells, including IFN-resistant strains.
  • Expression of cVAP-C also demonstrated significant suppression of HCV replication in infected cells.

Conclusions:

  • Engineered therapeutic molecules (cIRF7 and cVAP-C) show potent antiviral activity against HCV.
  • Selective activation within HCV-infected hepatocytes presents a feasible strategy for HCV elimination.
  • Further development and delivery to the liver could lead to a new therapeutic approach for hepatitis C patients.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...